Introduction to MOTS-c in Research
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16‑amino‑acid peptide encoded within the mitochondrial genome. First identified and characterized in 2015 by researchers at the University of Southern California, this peptide has attracted significant interest in molecular and cellular biology due to its proposed role in modulating metabolic pathways and cellular stress responses. Laboratory investigations focus on its translocation from the mitochondria to the nucleus under certain conditions, where it can influence the expression of nuclear genes involved in energy homeostasis.
In research settings, MOTS-c is primarily studied to understand mitochondrial communication with the nucleus—a process often referred to as mitonuclear crosstalk. Experimental models examine how the peptide interacts with folate‑dependent purine biosynthesis, AMP‑activated protein kinase (AMPK), and sirtuin pathways. These studies aim to elucidate fundamental mechanisms of metabolic regulation, insulin sensitivity, and age‑related physiological changes. All findings published to date are derived from in vitro cellular assays or animal models; no conclusions regarding human application can be drawn.
The growing demand for high‑purity MOTS-c in academic and pharmaceutical research laboratories has spurred development of robust supply chains. Investigators require the peptide in quantities ranging from milligrams for initial exploratory work to multi‑gram batches for more extensive longitudinal studies. All MOTS-c products referenced in this article are supplied exclusively for laboratory research purposes and are not intended for any in‑human or veterinary use.
Why Choose a Chinese Manufacturer for MOTS-c
China has become a significant hub for peptide synthesis, supported by decades of investment in chemical infrastructure and a large talent pool of synthetic organic chemists. When sourcing MOTS-c, many research procurement specialists consider Chinese manufacturers for several well‑documented operational advantages.
Advanced Synthesis Capabilities and Scalability
Leading Chinese peptide producers operate fully automated solid‑phase peptide synthesizers capable of handling synthesis scales from a few milligrams to hundreds of grams. This scalability means a single contract partner can support a project from early‑stage feasibility testing through to large‑scale preclinical investigations without requiring re‑validation of the synthetic route. Many facilities maintain reactor arrays for parallel synthesis, which improves throughput and reduces lead times for custom peptide requestions.
Competitive Cost Structures
The cost efficiency of Chinese manufacturing is not solely a function of labor. Integrated domestic supply chains for protected amino acids, coupling reagents, and high‑purity solvents diminish reliance on imported raw materials. Additionally, continuous power and utilities in dedicated industrial parks lower overhead, while proximity to major international shipping hubs streamlines export logistics. Buyers often observe that the combination of raw material access and optimized production workflows results in a lower cost per gram without compromising on the analytical specifications required for research-grade peptides.
Custom Synthesis and Modification Services
Beyond catalog MOTS-c, many Chinese peptide manufacturers offer tailored synthesis services. Common modifications requested by researchers include N‑terminal acetylation, C‑terminal amidation, or the incorporation of labeled amino acids (stable isotopes) for mass spectrometry‑based quantification. Some laboratories require the peptide with specific counter‑ions (e.g., acetate or trifluoroacetate) to match their experimental buffers. Reputable manufacturers will discuss sequence feasibility, solubility challenges, and provide preliminary purity data before undertaking a custom synthesis project.
Key Considerations When Selecting a MOTS-c Manufacturer
Identifying a dependable supplier requires systematic scrutiny of quality documentation and manufacturing practices. The following criteria are critical for researchers and procurement officers evaluating a MOTS‑c manufacturer in China.
Purity Assessment and Analytical Documentation
Research‑grade MOTS‑c should be characterized by high‑performance liquid chromatography (HPLC) and mass spectrometry (MS) as a minimum. A standard certificate of analysis (COA) will report the peptide’s purity, typically ≥95% or ≥98%, depending on the grade ordered, along with the HPLC retention time and the observed molecular ion peak consistent with the theoretical mass (theoretical monoisotopic mass of MOTS‑c is 2174.2 Da). Some suppliers include an HPLC chromatogram and an electrospray ionization mass spectrum directly on the COA, allowing the buyer to verify peak symmetry and the absence of deletion or truncated sequences.
Quality Control Beyond Primary Purity
Comprehensive quality control extends beyond HPLC and MS. For peptides used in cell‑based assays, endotoxin levels become relevant; a reliable manufacturer will test using the Limulus amebocyte lysate (LAL) method and report the result in EU/mg. Residual trifluoroacetic acid (TFA) from the cleavage step may interfere with certain biological assays, so quantification by ion chromatography or equivalent should be available. Water content, determined by Karl Fischer titration, and residual solvent analysis by gas chromatography are additional parameters that characterize the peptide’s suitability for quantitative research. Requesting a full analysis report before shipment is a standard industry practice.
Manufacturing Standards and Regulatory Compliance
While MOTS‑c is not a pharmaceutical product, a manufacturer’s adherence to quality management standards indicates a systematic approach to production. ISO 9001 certification confirms that the company follows documented procedures for process control and continuous improvement. Some peptide manufacturers have voluntarily adopted elements of Good Manufacturing Practice (GMP) for research chemicals, which can include batch traceability, equipment qualification, and environmental monitoring. If a research project expects to transition to IND‑enabling studies, it is prudent to inquire whether the manufacturer can provide documentation aligned with relevant regulatory guidelines, even though the current material is solely for laboratory investigation.
Manufacturing Process for MOTS-c Peptide
Understanding the synthetic route behind MOTS‑c helps researchers interpret batch‑to‑batch consistency and troubleshoot any experimental anomalies. The overwhelming majority of research‑grade MOTS‑c is produced via Fmoc solid‑phase peptide synthesis (SPPS).
Solid‑Phase Peptide Synthesis with Fmoc Chemistry
In SPPS, the C‑terminal amino acid of MOTS‑c (arginine) is anchored to a polymeric resin through a linker moiety. The Fmoc (9‑fluorenylmethoxycarbonyl) group temporarily protects the α‑amino function of each incoming amino acid. The synthesis cycle follows a repetitive sequence: deprotection of the Fmoc group using a base (commonly 20% piperidine in dimethylformamide), washing, activation of the next Fmoc‑protected amino acid with a coupling reagent (such as HBTU or HATU) in the presence of a base, coupling to the growing peptide chain, and final washing. Each step is monitored, often by conductivity or colorimetric tests, to ensure complete deprotection and coupling efficiency. Because MOTS‑c is a relatively short peptide (16 residues), the synthesis is typically straightforward, with low risk of aggregation‑related deletion products.
Cleavage, Deprotection, and Purification
After the last amino acid has been coupled, the peptide‑resin is treated with a cleavage cocktail—usually trifluoroacetic acid (TFA) with scavengers such as triisopropylsilane and water. This simultaneously releases the peptide from the resin and removes side‑chain protecting groups. The crude peptide is precipitated in cold diethyl ether, centrifuged, and dried. Subsequent purification is performed by reverse‑phase HPLC using a C18 column with a gradient of acetonitrile in water (both containing 0.1% TFA). Fractions matching the target purity are pooled and lyophilized to yield the final product as a white to off‑white powder. Ion exchange chromatography may be employed to reduce TFA content if the researcher requires acetate salt form.
Shipping and Logistics for Research Peptides
Receiving peptides in a condition that preserves their structural integrity is essential for experimental reproducibility. MOTS‑c, like many peptides, is hygroscopic and can be susceptible to oxidation or aggregation under inappropriate storage conditions.
Temperature‑Controlled Packaging
Manufacturers typically ship MOTS‑c in lyophilized form, often under vacuum or inert gas (argon or nitrogen), sealed in glass vials or high‑density polyethylene containers. For international shipments, especially during warmer months, cold chain packaging is employed. This may include gel ice packs, phase‑change materials, or dry ice, depending on the transit duration and destination. While lyophilized MOTS‑c is stable for short periods at ambient temperature, maintaining a low temperature (2–8°C or frozen) during carriage minimizes any risk of degradation. Upon arrival, researchers are advised to store the peptide as recommended on the material safety data sheet (MSDS), commonly at -20°C or below, protected from light and moisture.
Customs Clearance and Import Documentation
Cross‑border movement of research peptides demands accurate paperwork. A standard shipment will include a commercial invoice describing the product as a synthetic peptide for laboratory research use, the certificate of analysis, and the MSDS. The harmonized system (HS) code must correctly classify the product as a biochemical reagent. Any misdeclaration can cause delays. It is the purchaser’s responsibility to ascertain that the import of MOTS‑c complies with the regulations of the destination country. Some jurisdictions require an import license or a declaration from the receiving institution. Experienced Chinese manufacturers often assist by providing pre‑formatted documentation and sharing courier‑specific guidance, but they cannot assume legal responsibility for import clearance.
End‑User Accountability
All research chemicals, including MOTS‑c, are intended solely for bench‑top experimentation. The buyer assumes the obligation to use the material in accordance with institutional safety protocols and applicable laws. This includes proper handling, waste disposal, and ensuring that the peptide is not diverted for any non‑research purpose. Manufacturers routinely include a disclaimer on quotations and invoices reiterating the research‑only nature of the product.
Frequently Asked Questions (FAQ)
What is the typical lead time for a bulk order of MOTS‑c?
Lead times vary by manufacturer and order size. For catalog quantities (e.g., 10 mg to 1 g) many suppliers can dispatch within 3–7 business days after payment confirmation. Larger custom synthesis batches may require 2–4 weeks for production, purification, and quality control release. Always confirm the estimated shipment date in the proforma invoice.
How can I verify the identity of the MOTS‑c peptide upon receipt?
You can compare the mass spectrometry data on the COA with the theoretical molecular weight of 2174.2 Da. In‑house LC‑MS analysis on your own system, using a small aliquot, will confirm that the observed m/z values (typically the [M+3H]³⁺ and [M+4H]⁴⁺ ions) match the expected charge states. The HPLC retention time under the same chromatographic conditions should also be compatible.
Is it possible to order MOTS‑c in a salt form other than TFA?
Yes, many manufacturers offer acetate or hydrochloride salt conversion as a post‑purification step. Specify your requirement when requesting a quotation because salt conversion may slightly impact the net peptide content and should be reflected in the COA.
What shipping option is recommended for temperature‑sensitive peptides?
International courier services (e.g., FedEx, DHL) with temperature‑controlled packaging are standard. For destinations with extreme temperatures, manufacturers may recommend a validated shipper with phase‑change material and a temperature logger. Discuss the packaging configuration with the supplier before dispatch.
Can a manufacturer provide a sample for quality evaluation before a large purchase?
Many reputable firms will supply a small sample (often 1–5 mg) for a nominal fee or even free of charge, although the shipping cost is usually borne by the requester. This allows the research team to independently confirm purity and solubility in their specific assay buffer. Request the complete analytical data sheet with the sample.
Fazit
Selecting a reliable MOTS-c manufacturer in China requires a methodical evaluation of each supplier’s technical competence, quality control infrastructure, and transparency. By insisting on detailed HPLC and mass spectrometry data, comprehensive residual impurity reporting, and evidence of adherence to recognized quality management systems such as ISO 9001, research organizations can mitigate the risk of receiving substandard material. The established synthetic pipeline in China, rooted in Fmoc‑SPPS, is capable of delivering research‑grade MOTS‑c with the consistency demanded by rigorous experimental protocols.
Ultimately, a partnership built on clear communication, documented analytical specifications, and mutual understanding of regulatory boundaries serves the long‑term interests of the research community. Every interaction should reinforce the principle that these products exist solely to advance scientific knowledge through controlled laboratory investigation.
Research use only note: All information provided in this article pertains exclusively to the use of MOTS‑c as a research tool in laboratory settings. This peptide is not for human or animal application, and no therapeutic, diagnostic, or clinical use is suggested or implied. Any procurement must comply with all applicable local and international laws governing research chemicals.
Nur für Forschungszwecke. Nicht zur Anwendung am Menschen oder bei Tieren bestimmt.
